Keyword Search Year None2021202020192018201720162015201420132010 Date Title Media 11/12/21 Calithera to Present at the 2021 Jefferies London Healthcare Conference 11/09/21 Calithera Biosciences Reports Third Quarter 2021 Financial Results and Recent Highlights 11/05/21 Calithera Biosciences Announces Decision to Discontinue KEAPSAKE Clinical Trial 11/05/21 Calithera Biosciences Promotes Emil T. Kuriakose, MD, to Chief Medical Officer 11/02/21 Calithera Biosciences to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021 11/01/21 Calithera Presents Interim Data from Phase 1b Trial of Arginase Inhibitor CB-280 in Cystic Fibrosis at NACFC 2021 10/21/21 Calithera Biosciences to Present First Clinical Data from Development Program for Arginase Inhibitor CB-280 at NACFC 2021 10/18/21 Calithera Expands Oncology Pipeline with Acquisition of Two Clinical-Stage Assets from Takeda Pharmaceuticals 09/08/21 Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at the IASLC 2021 World Conference on Lung Cancer 09/02/21 Calithera Biosciences to Participate in Two Upcoming Investor Conferences 08/05/21 Calithera Biosciences Reports Second Quarter 2021 Financial Results and Recent Highlights 07/29/21 Calithera Biosciences to Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021 06/07/21 Final Data from Calithera Biosciences’ Phase 2 CANTATA Study in Renal Cell Carcinoma Presented at 2021 ASCO Annual Meeting 05/27/21 Calithera to Present at the Jefferies 2021 Virtual Healthcare Conference 05/17/21 Calithera Biosciences and Antengene Enter Worldwide License Agreement for Development & Commercialization of CB-708 05/06/21 Calithera Biosciences Reports First Quarter 2021 Financial Results and Recent Highlights 04/30/21 Calithera Biosciences to Report First Quarter 2021 Financial Results on Thursday, May 6, 2021 04/28/21 Results from Calithera Biosciences’ CANTATA Study to Be Presented at 2021 ASCO Annual Meeting 03/16/21 Calithera Biosciences Reports Fourth Quarter 2020 Financial Results and Recent Highlights 03/12/21 UPDATE – Calithera Biosciences to Report Fourth Quarter 2020 Financial Results on Tuesday, March 16, 2021 03/10/21 Calithera Biosciences to Report Fourth Quarter 2021 Financial Results on Tuesday, March 16, 2021 03/02/21 Calithera to Present at the H.C. Wainwright Virtual Global Life Sciences 2021 Conference 02/22/21 Calithera to Participate in the 10th Annual SVB Leerink Global Healthcare Conference 01/11/21 INCB001158 Biliary Tract Cancer Data to be Presented at 2021 Virtual ASCO Gastrointestinal Cancers Symposium 01/05/21 Calithera to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference 01/04/21 Calithera Biosciences Reports CANTATA Study of Telaglenastat in Renal Cell Carcinoma Did Not Achieve Primary Endpoint
